Cancer stem cells: Current status and future directions

2015 ◽  
Vol 205 (2) ◽  
pp. 124-125
Author(s):  
George Stoica
2006 ◽  
Vol 66 (19) ◽  
pp. 9339-9344 ◽  
Author(s):  
Michael F. Clarke ◽  
John E. Dick ◽  
Peter B. Dirks ◽  
Connie J. Eaves ◽  
Catriona H.M. Jamieson ◽  
...  

Tumor Biology ◽  
2014 ◽  
Vol 35 (9) ◽  
pp. 8395-8405 ◽  
Author(s):  
Ravindresh Chhabra ◽  
Neeru Saini

2018 ◽  
Vol 120 (3) ◽  
pp. 2766-2773 ◽  
Author(s):  
Amirhossein Bahreyni ◽  
Elnaz Ghorbani ◽  
Hamid Fuji ◽  
Mikhail Ryzhikov ◽  
Majid Khazaei ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-26
Author(s):  
Jiaxin Zhang ◽  
Yuzhe Liu ◽  
Yutong Chen ◽  
Lei Yuan ◽  
He Liu ◽  
...  

Adipose-derived stem cells (ADSCs) can maintain self-renewal and enhanced multidifferentiation potential through the release of a variety of paracrine factors and extracellular vesicles, allowing them to repair damaged organs and tissues. Consequently, considerable attention has increasingly been paid to their application in tissue engineering and organ regeneration. Here, we provide a comprehensive overview of the current status of ADSC preparation, including harvesting, isolation, and identification. The advances in preclinical and clinical evidence-based ADSC therapy for bone, cartilage, myocardium, liver, and nervous system regeneration as well as skin wound healing are also summarized. Notably, the perspectives, potential challenges, and future directions for ADSC-related researches are discussed. We hope that this review can provide comprehensive and standardized guidelines for the safe and effective application of ADSCs to achieve predictable and desired therapeutic effects.


2021 ◽  
Vol 1 (11) ◽  
pp. 2170111
Author(s):  
Elvan Dogan ◽  
Asli Kisim ◽  
Gizem Bati-Ayaz ◽  
Gregory J. Kubicek ◽  
Devrim Pesen-Okvur ◽  
...  

2019 ◽  
Vol 8 (5) ◽  
pp. 639 ◽  
Author(s):  
Vitalba Ruggieri ◽  
Sabino Russi ◽  
Pietro Zoppoli ◽  
Francesco La Rocca ◽  
Tiziana Angrisano ◽  
...  

Gastric cancer (GC) remains one of the major causes of cancer-related mortality worldwide. As for other types of cancers, several limitations to the success of current therapeutic GC treatments may be due to cancer drug resistance that leads to tumor recurrence and metastasis. Increasing evidence suggests that cancer stem cells (CSCs) are among the major causative factors of cancer treatment failure. The research of molecular CSC mechanisms and the regulation of their properties have been intensively studied. To date, molecular gastric cancer stem cell (GCSC) characterization remains largely incomplete. Among the GCSC-targeting approaches to overcome tumor progression, recent studies have focused their attention on microRNA (miRNA). The miRNAs are short non-coding RNAs which play an important role in the regulation of numerous cellular processes through the modulation of their target gene expression. In this review, we summarize and discuss recent findings on the role of miRNAs in GCSC regulation. In addition, we perform a meta-analysis aimed to identify novel miRNAs involved in GCSC homeostasis.


Cancers ◽  
2011 ◽  
Vol 3 (2) ◽  
pp. 1777-1797 ◽  
Author(s):  
Sabrina Facchino ◽  
Mohamed Abdouh ◽  
Gilbert Bernier

2012 ◽  
Vol 10 (6) ◽  
pp. 717-728 ◽  
Author(s):  
Jane E. Visvader ◽  
Geoffrey J. Lindeman

Sign in / Sign up

Export Citation Format

Share Document